摘要 |
The purpose of the present invention is to provide a pharmaceutical composition which can be dissolved well in a neutral region and contains a compound (I), a pharmacologically acceptable salt of the compound, or a solvate of the compound or the pharmacologically acceptable salt as an active ingredient. The present invention relates to a pharmaceutical composition comprising (A) N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4- [(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}- cyclohexyl)ethanediamide, a pharmacologically acceptable salt of the compound, or a solvate of the compound or the pharmacologically acceptable salt and (B) an acid or a salt thereof. |